Liver steatosis is an independent risk factor for treatment failure in patients with chronic hepatitis C

Abstract

Steatosis in the liver biopsy performed before the beginning of antiviral treatment was found to be associated only to the body mass index of the patients and to be a strong independent factor for treatment failure.